Journal

Inorganic chemistry
ISSN: 1520-510X
Titre abrégé: Inorg Chem
Pays: United States
ID NLM: 0366543

Informations de publication

Date de publication:
08 Sep 2020
Historique:
pubmed: 18 7 2020
medline: 18 7 2020
entrez: 18 7 2020
Statut: ppublish

Résumé

Recent clinical results have demonstrated remarkable treatment responses of late-stage cancer patients when treated with alpha-emitting radionuclides such as actinium-225 (

Identifiants

pubmed: 32677829
doi: 10.1021/acs.inorgchem.0c01081
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12156-12165

Auteurs

Andrew K H Robertson (AKH)

Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z1.
Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada V6T 2A3.

Brooke L McNeil (BL)

Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada V6T 2A3.
Department of Chemistry, University of Waterloo, Waterloo, Ontario, Canada N2L 3G1.

Hua Yang (H)

Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada V6T 2A3.

Denise Gendron (D)

Canadian Nuclear Laboratories, Chalk River, Ontario, Canada K0J 1J0.

Randy Perron (R)

Canadian Nuclear Laboratories, Chalk River, Ontario, Canada K0J 1J0.

Valery Radchenko (V)

Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada V6T 2A3.
Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z1.

Stefan Zeisler (S)

Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada V6T 2A3.

Patrick Causey (P)

Canadian Nuclear Laboratories, Chalk River, Ontario, Canada K0J 1J0.

Paul Schaffer (P)

Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada V6T 2A3.
Department of Chemistry, Simon Fraser University, Vancouver, British Columbia, Canada V5A 1S6.
Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada V5Z 1M9.

Classifications MeSH